EDGAR Filing Documents for 0001415889-17-001001

Form D - Notice of Exempt Offering of Securities:

SEC Accession No. 0001415889-17-001001

Filing Date

2017-06-15

Accepted

2017-06-15 13:14:40

Documents

Effectiveness Date

2017-06-15

Items

Item 06b:

Document Format Files

Seq	Description	Document	Type	Size
1		primary_doc.html	D
1		primary_doc.xml	D	9879
	Complete submission text file	0001415889-17-001001.txt		11084

Mailing Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226

Business Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226 646-699-7855

AzurRx BioPharma, Inc. (Filer) CIK: 0001604191 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: D | Act: 33 | File No.: 021-288822 | Film No.: 17912997
SIC: 2834 Pharmaceutical Preparations